1. Shah NL, Northup PG, Caldwell SH. A clinical survey of bleeding, thrombosis, and blood product use in decompensated cirrhosis patients. Ann Hepatol. 2012; 11:686–90. PMID:
22947530.
2. Shah NL, Caldwell SH. Assessing the risk of bleeding and clotting in cirrhosis. Clin Liver Dis. 2016; 7:26–8. DOI:
10.1002/cld.528.
3. Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease:evidence and clinical consequences. Blood. 2010; 116:878–85. DOI:
10.1182/blood-2010-02-261891. PMID:
20400681.
4. Henry Z, Northup PG. The rebalanced hemostasis system in end-stage liver disease and its impact on liver transplantation. Int Anesthesiol Clin. 2017; 55:107–20. DOI:
10.1097/AIA.0000000000000139. PMID:
28221169.
5. Lisman T, Leebeek FW, Mosnier LO, Bouma BN, Meijers JC, Janssen HL, et al. Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis. Gastroenterology. 2001; 121:131–9. DOI:
10.1053/gast.2001.25481. PMID:
11438502.
6. Weeder PD, Porte RJ, Lisman T. Hemostasis in liver disease:implications of new concepts for perioperative management. Transfus Med Rev. 2014; 28:107–13. DOI:
10.1016/j.tmrv.2014.03.002. PMID:
24721432.
7. Ganter MT, Hofer CK. Coagulation monitoring:current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg. 2008; 106:1366–75. DOI:
10.1213/ane.0b013e318168b367. PMID:
18420846.
8. Hartmann M, Szalai C, Saner FH. Hemostasis in liver transplantation:pathophysiology, monitoring, and treatment. World J Gastroenterol. 2016; 22:1541–50. DOI:
10.3748/wjg.v22.i4.1541. PMID:
26819521. PMCID:
PMC4721987.
9. Kim TY. Perioperative bleeding disorder and intraoperative ponit-of-care testing of coagulation during cardiac surgery. Anesth Pain Med. 2011; 6:1–15.
10. Kaufman RM, Djulbegovic B, Gernsheimer T, Kleinman S, Tinmouth AT, Capocelli KE, et al. Platelet transfusion:a clinical practice guideline from the AABB. Ann Intern Med. 2015; 162:205–13. DOI:
10.7326/M14-1589. PMID:
25383671.